CRNX vs UHS · rev $35.9M vs P/E 5.9, rev $9.13B
Crinetics Pharmaceuticals Inc (CRNX) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
CRNX currently screens at market cap $2.76B. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the CRNX and UHS stock pages for the full models.
Not investment advice.